Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study

BACKGROUND: The inhaled corticosteroid (ICS) fluticasone propionate (fluticasone) and the long-acting β(2)-agonist (LABA) formoterol fumarate (formoterol) are being made available as a combination product (fluticasone/formoterol, flutiform(®)) in a single aerosol inhaler. This 12-week, open-label, r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bodzenta-Lukaszyk, Anna, Dymek, Andrzej, McAulay, Kirsten, Mansikka, Heikki
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2011
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3146950/
https://ncbi.nlm.nih.gov/pubmed/21605396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-11-28
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge